Global Propranolol Hydrochloride Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: March 2, 2021 |

The global propranolol hydrochloride market size is accounted to register a significant CAGR of 2.6% during the forecast period 2021 to 2027 and expected to reach around USD 880 million by 2027. In 2019, the market size was estimated at USD 707 million. The increasing incidence of cardiac complications is a major factor to drive the market growth. Furthermore, the rising prevalence of hypertension and changing lifestyle in developed economies are some other factors to propel the market. Moreover, the increasing investment in research and development and advancement in the pharmaceuticals industry is expected to fuel the market over the forecast period. However, side effects associated with it such as allergic reaction, change in blood sugar, and breathing problem is expected to restrain the market growth.

Market Segment Insights:

The global propranolol hydrochloride market is bifurcated into clinical application, distribution channel, and geography. On the basis of clinical application, the market is further segmented into hypertension, migraine, and others. The hypertension segment is accounted to hold the largest market share in terms of revenue and expected to maintain its dominance over the forecast period. The segment growth is attributed to the increasing incidence of hypertension and changing lifestyle in developed countries. According to the latest information shared by the WHO, around 1.13 billion people are suffering from hypertension across the globe. The increasing consumption of alcohol and tobacco by the young population and increasing stressful lifestyle is expected to support the segment growth over the forecast period.

On the basis of distribution channel, the hospital pharmacies dominated the propranolol hydrochloride market. The side effects associated with the drug such as insomnia, restlessness, the drug should be delivered under the supervision of the hospital pharmacy which is supporting the segment growth. The distribution channel segment is divided into its sub-segment hospital pharmacy, retail pharmacy, and others.

Propranolol Hydrochloride Market Size & Growth

To know more about the study, request a report sample

The propranolol hydrochloride comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The propranolol hydrochloride market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Global Propranolol Hydrochloride Market Segmentation:

By Clinical Application:

  • Hypertension
  • Migraine
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, the propranolol hydrochloride market report comprises dedicated sections centering on the regional market revenue and trends. The propranolol hydrochloride market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The propranolol hydrochloride market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Propranolol hydrochloride market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Market Competition Assessment:

Key players operating in the global propranolol hydrochloride market are Mylan Pharmaceutical Industries Limited., Lupin Pharma. , AstraZeneca, Plc., Teva Pharmaceutical Industries Limited., and Sandoz, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Mylan Pharmaceutical Industries Limited.
  • Lupin Pharma.
  • AstraZeneca, Plc.
  • Teva Pharmaceutical Industries Limited.
  • Sandoz, Inc.
  • Accord Healthcare
  • Aurobindo Pharma
  • Pierre Fabre
  • Helvepharm AG
  • Apotex Corporation

Key Questions Answered by Propranolol hydrochloride Market Report:

  • Global propranolol hydrochloride market forecasts from 2021-2027
  • Regional propranolol hydrochloride market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Propranolol hydrochloride submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to propranolol hydrochloride market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level propranolol hydrochloride markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the propranolol hydrochloride market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Propranolol Hydrochloride Market Portraiture
2.2. Global Propranolol Hydrochloride Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Propranolol Hydrochloride Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Propranolol Hydrochloride Market, by Geography, 2020 (USD Mn)

 

3. Global Propranolol Hydrochloride Market Analysis


3.1. Propranolol Hydrochloride Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Propranolol Hydrochloride Market By Clinical Application, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Hypertension
4.3. Migraine
4.4. Others

 

5. Global Propranolol Hydrochloride Market By Distribution Channel, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

 

6. North America Propranolol Hydrochloride Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Propranolol Hydrochloride Market by Clinical Application (2018-2027 USD Mn)
6.1.3. North America Propranolol Hydrochloride Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Propranolol Hydrochloride Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada

 

7. Europe Propranolol Hydrochloride Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Propranolol Hydrochloride Market by Clinical Application (2018-2027 USD Mn)
7.1.3. Europe Propranolol Hydrochloride Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Propranolol Hydrochloride Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe

 

8. Asia Pacific Propranolol Hydrochloride Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Propranolol Hydrochloride Market by Clinical Application (2018-2027 USD Mn)
8.1.3. Asia Pacific Propranolol Hydrochloride Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Propranolol Hydrochloride Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific

 

9. Latin America (LATAM) Propranolol Hydrochloride Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Propranolol Hydrochloride Market by Clinical Application (2018-2027 USD Mn)
9.1.3. Latin America Propranolol Hydrochloride Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Propranolol Hydrochloride Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America

 

10. Middle East and Africa Propranolol Hydrochloride Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Propranolol Hydrochloride Market by Clinical Application (2018-2027 USD Mn)
10.1.3. MEA Propranolol Hydrochloride Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Propranolol Hydrochloride Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA

 

11. Company Profiles


11.1. Mylan Pharmaceutical Industries Limited.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Lupin Pharma.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. AstraZeneca, Plc.
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Teva Pharmaceutical Industries Limited.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Sandoz, Inc.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Accord Healthcare
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Aurobindo Pharma
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Pierre Fabre
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Helvepharm AG
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Apotex Corporation
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Propranolol Hydrochloride Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to the request, please read our FAQs below)
(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Propranolol Hydrochloride Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients